298 related articles for article (PubMed ID: 25690407)
1. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.
Waters VJ; Stanojevic S; Sonneveld N; Klingel M; Grasemann H; Yau YC; Tullis E; Wilcox P; Freitag A; Chilvers M; Ratjen FA
J Cyst Fibros; 2015 Nov; 14(6):755-62. PubMed ID: 25690407
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
[TBL] [Abstract][Full Text] [Related]
5. Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.
Aaron SD; Vandemheen KL; Ferris W; Fergusson D; Tullis E; Haase D; Berthiaume Y; Brown N; Wilcox P; Yozghatlian V; Bye P; Bell S; Chan F; Rose B; Jeanneret A; Stephenson A; Noseworthy M; Freitag A; Paterson N; Doucette S; Harbour C; Ruel M; MacDonald N
Lancet; 2005 Aug 6-12; 366(9484):463-71. PubMed ID: 16084254
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.
Sagel SD; Thompson V; Chmiel JF; Montgomery GS; Nasr SZ; Perkett E; Saavedra MT; Slovis B; Anthony MM; Emmett P; Heltshe SL
Ann Am Thorac Soc; 2015 May; 12(5):708-17. PubMed ID: 25714657
[TBL] [Abstract][Full Text] [Related]
7. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
[TBL] [Abstract][Full Text] [Related]
8. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
[TBL] [Abstract][Full Text] [Related]
9. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials.
Mayer-Hamblett N; Saiman L; Lands LC; Anstead M; Rosenfeld M; Kloster M; Fisher L; Ratjen F
Contemp Clin Trials; 2013 Sep; 36(1):99-105. PubMed ID: 23770109
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic duration and changes in FEV
Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary exacerbations in cystic fibrosis.
Rabin HR; Butler SM; Wohl ME; Geller DE; Colin AA; Schidlow DV; Johnson CA; Konstan MW; Regelmann WE;
Pediatr Pulmonol; 2004 May; 37(5):400-6. PubMed ID: 15095322
[TBL] [Abstract][Full Text] [Related]
13. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis.
Waters V; Atenafu EG; Salazar JG; Lu A; Yau Y; Matukas L; Tullis E; Ratjen F
J Cyst Fibros; 2012 Jan; 11(1):8-13. PubMed ID: 21849265
[TBL] [Abstract][Full Text] [Related]
14. Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers.
Kraynack NC; Gothard MD; Falletta LM; McBride JT
Pediatr Pulmonol; 2011 Sep; 46(9):870-81. PubMed ID: 21465675
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary exacerbations in cystic fibrosis.
Stenbit AE; Flume PA
Curr Opin Pulm Med; 2011 Nov; 17(6):442-7. PubMed ID: 21881509
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
Sharma A; Kirkpatrick G; Chen V; Skolnik K; Hollander Z; Wilcox P; Quon BS
PLoS One; 2017; 12(2):e0171229. PubMed ID: 28178305
[TBL] [Abstract][Full Text] [Related]
17. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
18. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria.
Block JK; Vandemheen KL; Tullis E; Fergusson D; Doucette S; Haase D; Berthiaume Y; Brown N; Wilcox P; Bye P; Bell S; Noseworthy M; Pedder L; Freitag A; Paterson N; Aaron SD
Thorax; 2006 Nov; 61(11):969-74. PubMed ID: 16844728
[TBL] [Abstract][Full Text] [Related]
19. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]